Table 1.
Characteristics of the present study
| The characteristics | Mean±SD, n (%) |
|---|---|
| n | 84 |
| T2DM | 54 (64.28) |
| Healthy subjects (control) | 30 (35.71) |
| Age (years) | |
| T2DM | 56.23±5.99 |
| Control | 55.69±5.87 |
| Race, white: black ratio | 90:4 |
| Duration of T2DM (months) | 2-4 |
| Current pharmacotherapy | |
| M | 24 (44.44) |
| M+Co | 30 (55.55) |
| Antihypertensive drugs | |
| Amlodipine | 33 (61.11) |
| B-blockers | 5 (9.25) |
| Statins | 21 (38.88) |
| Fenofibrate | 41 (75.92) |
| Aspiri | 45 (83.33) |
| Duration of the study (weeks) | 8 |
Data are presented as mean±SD, n (%). SD=Standard deviation, T2DM=Type 2 diabetes mellitus, CoQ10=Coenzyme Q10, M=Metformin, M+Co=Metformin plus CoQ10